General Information
Version
1.3
Revision date
2022-03-03
Product name
Sucrase plus β-Galactosidase
1.2.1 Relevant identified uses
Industrial/Professional use spec
Manufacturer Name
Megazyme
Emergency telephone
+353 12861220
Icons in SDS
Company Information
company name
Megazyme
e-mail address of the competent person responsible for the Safety Data Sheet
cs@megazyme.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H334
Hazard statements
Code
Statements
H334
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Section 2
SECTION 2: Hazards identification
According to Regulation (EC) No. 1272/2008 (CLP) Classification of the substance or mixture
Adverse physicochemical, human health and environmental effects
May cause allergy or asthma symptoms or breathing difficulties if inhaled
Hazard pictograms
GHS08 GHS08
Signal word
Danger
Contains
Glucosidase (alpha), maltase; Galactosidase, β-
Hazard statements
H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
Precautionary statements
P261 - Avoid breathing dust. P284 - Wear respiratory protection. P304+P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing. P342+P311 - If experiencing respiratory symptoms: Call a doctor, a POISON CENTER. P501 - Dispose of contents/container to hazardous or special waste collection point, in accordance with local, regional, national and/or international regulation. Labelling according to: exemption for inner packaging where the contents do not exceed 10ml
Hazardous Ingredients
Glucosidase (alpha), maltase; Galactosidase, β-
2.3 Other hazards
No additional information available
2.1 Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP] Respiratory sensitisation, Category 1 H334 Full text of H-statements: see section 16 Adverse physicochemical, human health and environmental effects May cause allergy or asthma symptoms or breathing difficulties if inhaled.
